I tend to agree with Satyr. I think everyone would have to agree that the ultimate success of AHZ will likely depend on the success of their Adapt technology. At the moment the growth of Cardiocell is not happening at a fast enough rate which is why I believe the share price is sluggish. Can they get the growth required? I hope so..
Possible take over, page-12
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.68 |
Change
-0.220(1.71%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $12.71 | $12.71 | $12.50 | $75.07K | 5.937K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 626 | $12.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.66 | 41 | 1 |
View Market Depth
| Last trade - 11.27am 18/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |